Agenus to provide corporate update and third quarter 2022 financial report

Lexington, mass., oct. 25, 2022 (globe newswire) -- agenus (nasdaq: agen) an immuno-oncology company with an extensive pipeline of therapeutics designed to activate the immune response to cancers and infections, today announced the company will release its second quarter 2022 financial results before the market opens on tuesday, november 8, 2022. agenus executives will host a conference call and webcast at 8:30 a.m. et that morning to discuss the results and to provide a corporate update.
AGEN Ratings Summary
AGEN Quant Ranking